LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 179 filers reported holding LEMAITRE VASCULAR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276 | -6.8% | 6 | -88.2% | 0.00% | -100.0% |
| Q1 2023 | $296 | -99.9% | 51 | -66.7% | 0.01% | -10.0% |
| Q3 2022 | $292,000 | +11.0% | 153 | +10.9% | 0.01% | +25.0% |
| Q2 2022 | $263,000 | -1.5% | 138 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $267,000 | -7.3% | 138 | -8.0% | 0.01% | 0.0% |
| Q4 2021 | $288,000 | +443.4% | 150 | +2400.0% | 0.01% | -72.0% |
| Q3 2021 | $53,000 | -13.1% | 6 | -90.8% | 0.02% | +13.6% |
| Q2 2021 | $61,000 | -98.1% | 65 | -3.0% | 0.02% | -67.2% |
| Q1 2021 | $3,276,000 | – | 67 | +1016.7% | 0.07% | – |
| Q4 2020 | $0 | -100.0% | 6 | -14.3% | 0.00% | -100.0% |
| Q1 2020 | $176,000 | +388.9% | 7 | -98.7% | 0.00% | -96.0% |
| Q4 2019 | $36,000 | -5.3% | 551 | -59.2% | 0.02% | -37.5% |
| Q3 2018 | $38,000 | +1800.0% | 1,352 | +2776.6% | 0.04% | +1900.0% |
| Q2 2018 | $2,000 | -93.5% | 47 | -94.9% | 0.00% | -93.8% |
| Q1 2018 | $31,000 | – | 929 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |